Female Founders Award 2023 | Apply or Nominate Now!
On April 26, 2023, the American Chamber of Commerce in Germany (AmCham Germany) will present its Female Founders Award for the fourth time in Berlin.
1 Min
More 
Announcement of the Winners of the 2022 CAAT Humane Education Award
Congratulations to Dr. Vivian Kral and Dr. Christian Zoschke from Free University Berlin, Germany, who won the 2022 CAAT Humane Education Award for their project titled “3Rs Info Hub PRO - Your go-to place for training on non-animal research”.
Each…
1 Min
More Bayer to Accelerate Drug Discovery with Google Cloud’s High-Performance Compute Power
Bayer to speed up its in-silico research and development with Google Cloud’s high-speed processors / Collaboration aims to enable Bayer to run large quantum chemistry calculations at scale using Google Tensorflow Processing Units
3 Min
More ProBioGen Collaborates with Boehringer Ingelheim on DirectedLuck® Transposase Technology
ProBioGen announced today a new non-exclusive collaboration with Boehringer Ingelheim on ProBioGen's DirectedLuck® transposase technology.
2 Min
More Review: "The Product is the Process – Is it?" Manufacturing and Translation of ATMPs and Tissue- & Cell-based products
An event held in cooperation with the Biotechnologieverbund Berlin-Brandenburg e.V., BBB; the Paul-Ehrlich-Institut; the Central Authority of the Länder for Health Protection with regard to Medicinal Products and Medical Devices, ZLG; the German Stem…
2 Min
More DSM chooses LabTwin to advance their digitalization strategy in Science & Innovation with the latest voice and AI solutions.
DSM rolls out Labtwin's AI and voice powered digital lab assistant
Today, Royal DSM N.V., a global company specializing in health, nutrition, and sustainable living, and LabTwin GmbH, the leading voice and AI-powered digital lab assistant, announce…
3 Min
More Therabest and Glycotope to assess Therabest’s iPSC-derived NK cell product TB-100 in combination with Glycotope’s GT-00AxIL15 immuno-cytokine for development in triple negative breast cancer
Therabest and Glycotope to assess Therabest’s iPSC-derived NK cell product TB-100 in combination with Glycotope’s GT-00AxIL15 immuno-cytokine for development in triple negative breast cancer
4 Min
More OMEICOS Therapeutics Announces Expansion of OMT-28 Clinical Development Program into Primary Mitochondrial Diseases
OMT-28’s established safety profile, biomarker data, and funding secured from existing investors enable swift transition into a Phase II clinical study
2 Min
More Interview | Prof. Dr. rer. nat. Heyo K. Kroemer, Chief Executive Officer of Charité – Universitätsmedizin Berlin
Diverse challenges and opportunities
3 Min
More Special Topic | This is how the German capital region supports founders
The Berlin-Brandenburg capital region is one of the leading life science regions in Europe and a lot is being done to keep it that way: with a wide variety of space offerings and support program for founders and start-ups.
5 Min
More Show more items
